Medicare & Medicaid
News articles in this section include actions by federal regulators like the CMS and HHS, as well as information on Medicare and state Medicaid coverage and benefits.
Momentum is building among House Democrats for a more moderate alternative to single-payer health-care legislation.
Momentum is building among House Democrats for a more moderate alternative to single-payer health-care legislation.
Insurers that participate in Medicare’s prescription drug program would be able to exclude certain drugs if prices rise faster than inflation as part of a new proposal from the Trump administration.
It remains to be seen how disruptive Amazon will be in the prescriptions space now that it has its own online pharmacy. The company snagged PillPack, which focuses on delivering individualized rolls of presorted medicines to people who manage multiple daily medications.
Traditional tax-qualified long-term care insurance policies now have new tax deductibility limits, according to the IRS.
U.S. health officials said Monday they plan to overhaul the nation’s decades-old system for approving most medical devices, which has long been criticized by experts for failing to catch problems with risky implants and related products.
A draft Trump administration rule that would penalize immigrants seeking green cards for accessing social services — including Medicaid — could cause thousands of kids to lose their health insurance, some advocates fear.
HealthCare.gov signup activity continued to improve during the third week of the open enrollment period for individual major medical coverage that starts Jan. 1, 2019. Managers of the Affordable Care Act public exchange enrollment and administration system report that 748,244 households selected plans during the third week of the 2019 open enrollment period, which ended Nov. 17.
In order to capitalize on the opioid crisis, a small company that sells a version of naloxone, a decades-old drug that is widely used to reverse the effect of opioid and heroin overdoses, raised the price of its product by more than 600 percent between 2014 and 2017, which cost the federal government more than $142 million, according to a lengthy report from a Senate subcommittee.
Democrats will scrutinize the Trump administration’s decision not to defend Obamacare in federal court, when Democrats take control of the U.S. House of Representatives next year, a leading Democrat said on Monday.